Research Trial for Participants with Vitiligo (14 Months)

Individuals aged 12 or older with a clinical diagnosis of nonsegmental vitiligo with depigmented areas, may qualify to participate. Qualified participants must agree to discontinue all agents used to treat vitiligo from screening through the final safety follow-up visit. Participants must not have other forms of vitiligo (e.g. segmental) or other differential diagnosis of vitiligo or other skin depigmentation disorders.

Participants will receive investigational topical cream (active Study Drug) either alone or in combination with home-based phototherapy. Study medication, phototherapy device, and study-related assessments will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 14 months and involve about 10 visits to the study centre, plus a safety follow-up visit.

Call the study centre near you, or register now.

Learn more about
Vitiligo
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more